Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C119129 |
18alpha-glycyrrhetinic acid |
18alpha-glycyrrhetinic acid affects the activity of AKR1C3 protein | affects activity | 11165023
|
C031903 |
1-UFT protocol |
AKR1C3 protein results in increased susceptibility to 1-UFT protocol | increases response to substance | 16734730
|
C520534 |
2'-hydroxyflavanone |
2'-hydroxyflavanone results in decreased activity of AKR1C3 protein | decreases activity | 19007764
|
C429845 |
7-hydroxyflavone |
7-hydroxyflavone results in decreased activity of AKR1C3 protein | decreases activity | 19007764
|
C005399 |
9,10-phenanthrenequinone |
AKR1C3 protein results in increased metabolism of 9,10-phenanthrenequinone | increases metabolic processing | 17950253
|
C005399 |
9,10-phenanthrenequinone |
AKR1C3 protein results in increased reduction of 9,10-phenanthrenequinone | increases reduction | 19442656
|
C005399 |
9,10-phenanthrenequinone |
[AKR1C3 protein results in increased reduction of 9,10-phenanthrenequinone] which results in increased abundance of Superoxides | increases abundance|increases reduction | 19442656
|
C005399 |
9,10-phenanthrenequinone |
Indomethacin analog inhibits the reaction [AKR1C3 protein results in increased metabolism of 9,10-phenanthrenequinone] | decreases reaction|increases metabolic processing | 17950253
|
C005399 |
9,10-phenanthrenequinone |
Indomethacin inhibits the reaction [AKR1C3 protein results in increased metabolism of 9,10-phenanthrenequinone] | decreases reaction|increases metabolic processing | 17950253
|
C005399 |
9,10-phenanthrenequinone |
N-(4-chlorobenzoyl)melatonin inhibits the reaction [AKR1C3 protein results in increased metabolism of 9,10-phenanthrenequinone] | decreases reaction|increases metabolic processing | 17950253
|
D000735 |
Androstenedione |
AKR1C3 protein results in increased reduction of Androstenedione | increases reduction | 17950253
|
D000735 |
Androstenedione |
Indomethacin analog inhibits the reaction [AKR1C3 protein results in increased reduction of Androstenedione] | decreases reaction|increases reduction | 17950253
|
D000735 |
Androstenedione |
Indomethacin inhibits the reaction [AKR1C3 protein results in increased reduction of Androstenedione] | decreases reaction|increases reduction | 17950253
|
D000735 |
Androstenedione |
N-(4-chlorobenzoyl)melatonin inhibits the reaction [AKR1C3 protein results in increased reduction of Androstenedione] | decreases reaction|increases reduction | 17950253
|
D047310 |
Apigenin |
Apigenin results in decreased activity of AKR1C3 protein | decreases activity | 16023337
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of AKR1C3 mRNA | increases expression | 19128835
|
D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone results in increased expression of AKR1C3 mRNA | increases expression | 19737606
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of AKR1C3 mRNA | increases expression | 20106945
|
C095105 |
bexarotene |
bexarotene results in increased expression of AKR1C3 mRNA | increases expression | 17178900
|
C004541 |
biochanin A |
biochanin A results in decreased activity of AKR1C3 protein | decreases activity | 19007764
|
C110904 |
capecitabine |
AKR1C3 protein results in increased susceptibility to capecitabine | increases response to substance | 16734730
|
D003375 |
Coumestrol |
Coumestrol results in decreased activity of AKR1C3 protein | decreases activity | 19007764
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of AKR1C3 mRNA | increases expression | 19665456
|
D004054 |
Diethylstilbestrol |
sodium arsenite promotes the reaction [Diethylstilbestrol results in increased expression of AKR1C3 mRNA] | increases expression|increases reaction | 19665456
|
C025034 |
doxifluridine |
AKR1C3 protein results in increased susceptibility to doxifluridine | increases response to substance | 16734730
|
D004317 |
Doxorubicin |
AKR1C3 protein affects the reduction of Doxorubicin | affects reduction | 18635746
|
C108373 |
dutasteride |
dutasteride results in increased expression of AKR1C3 mRNA | increases expression | 16806904
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of AKR1C3 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of AKR1C3 mRNA | decreases expression | 19619570
|
D015025 |
Zearalenone |
Zearalenone results in decreased activity of AKR1C3 protein | decreases activity | 16023337
|
D005439 |
Flufenamic Acid |
Flufenamic Acid binds to AKR1C3 protein | affects binding | 14996743
|
D005439 |
Flufenamic Acid |
Flufenamic Acid results in decreased activity of AKR1C3 protein | decreases activity | 19007764 19442656
|
D005472 |
Fluorouracil |
AKR1C3 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
D005472 |
Fluorouracil |
Fluorouracil affects the expression of AKR1C3 mRNA | affects expression | 16584549
|
C071834 |
glycidamide |
glycidamide results in increased expression of AKR1C3 mRNA | increases expression | 17822822
|
D007213 |
Indomethacin |
Indomethacin analog inhibits the reaction [AKR1C3 protein results in increased metabolism of 9,10-phenanthrenequinone] | decreases reaction|increases metabolic processing | 17950253
|
D007213 |
Indomethacin |
Indomethacin analog inhibits the reaction [AKR1C3 protein results in increased reduction of Androstenedione] | decreases reaction|increases reduction | 17950253
|
D007213 |
Indomethacin |
Indomethacin analog results in decreased activity of AKR1C3 protein | decreases activity | 17950253
|
D007213 |
Indomethacin |
Indomethacin binds to AKR1C3 protein | affects binding | 14996743
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [AKR1C3 protein results in increased metabolism of 9,10-phenanthrenequinone] | decreases reaction|increases metabolic processing | 17950253
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [AKR1C3 protein results in increased reduction of Androstenedione] | decreases reaction|increases reduction | 17950253
|
D007213 |
Indomethacin |
Indomethacin results in decreased activity of AKR1C3 protein | decreases activity | 17950253
|
D007213 |
Indomethacin |
Indomethacin results in decreased activity of AKR1C3 protein | decreases activity | 19442656 19007764
|
C526888 |
N-(4-chlorobenzoyl)melatonin |
N-(4-chlorobenzoyl)melatonin inhibits the reaction [AKR1C3 protein results in increased metabolism of 9,10-phenanthrenequinone] | decreases reaction|increases metabolic processing | 17950253
|
C526888 |
N-(4-chlorobenzoyl)melatonin |
N-(4-chlorobenzoyl)melatonin inhibits the reaction [AKR1C3 protein results in increased reduction of Androstenedione] | decreases reaction|increases reduction | 17950253
|
C526888 |
N-(4-chlorobenzoyl)melatonin |
N-(4-chlorobenzoyl)melatonin results in decreased activity of AKR1C3 protein | decreases activity | 17950253
|
C005273 |
naringenin |
naringenin results in decreased activity of AKR1C3 protein | decreases activity | 19007764
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of AKR1C3 mRNA | increases expression | 17681415
|
D011794 |
Quercetin |
Quercetin results in decreased activity of AKR1C3 protein | decreases activity | 19007764
|
D011794 |
Quercetin |
Quercetin results in decreased activity of AKR1C3 protein | decreases activity | 16023337
|
C079198 |
S 1 (combination) |
AKR1C3 protein results in increased susceptibility to S 1 (combination) | increases response to substance | 16734730
|
C440975 |
silybin |
silybin results in decreased activity of AKR1C3 protein | decreases activity | 19007764
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of AKR1C3 mRNA | increases expression | 19696165 12727804
|
C017947 |
sodium arsenite |
sodium arsenite promotes the reaction [Diethylstilbestrol results in increased expression of AKR1C3 mRNA] | increases expression|increases reaction | 19665456
|
D013481 |
Superoxides |
[AKR1C3 protein results in increased reduction of 9,10-phenanthrenequinone] which results in increased abundance of Superoxides | increases abundance|increases reduction | 19442656
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of AKR1C3 mRNA | increases expression | 15507505
|
D013739 |
Testosterone |
AKR1C3 promoter SNP results in increased abundance of Testosterone | increases abundance | 16263811
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of AKR1C3 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of AKR1C3 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of AKR1C3 mRNA | decreases expression | 19619570
|
D014501 |
Uranium |
Uranium affects the expression of AKR1C3 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of AKR1C3 mRNA | affects expression | 15672453
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.46 | 15322242 11752688 14514962 |
MESH:D058186 |
Acute Kidney Injury |
|
Superoxides |
4.75 | 18460982 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
15.64 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
15.64 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
15.64 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
15.64 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
15.64 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
15.64 | 16537180 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
9.93 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
9.93 | 19389873 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
9.93 | 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.30 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.50 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.17 | 21441931 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.97 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
2.61 | 17627676 15579461 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.11 | 15469931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.55 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.55 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.89 | 17084956 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Superoxides |
5.27 | 16910769 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.45 | 7506515 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.47 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
10.43 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
10.43 | 10388637 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.77 | 2160914 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
2.73 | 11248219 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.58 | 15336622 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.02 | 19761891 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.60 | 10684365 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
7.79 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.79 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.39 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.51 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.30 | 14601052 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.62 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
4.03 | 12524144 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.47 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Apigenin |
10.48 | 16541309 17132221 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
10.48 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
10.48 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
10.48 | 18473752 12972520 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
10.48 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
10.48 | 18234424 15634643 16096432 15692762 15668708 16826403 15994142 15993339 11325840 18695136 17369602 17426702 18628466 15567936 16115903 16322301 17983394 16935488 18382427 16595493 15136595 16264153 15939500 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
dutasteride |
10.48 | 16806904 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
10.48 | 16675129 18497071 12948864 17289903 17018787 19861407 14630087 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
10.48 | 16595493 16110121 19217205 18357371 18608205 16557594 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
10.48 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
10.48 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
10.48 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
10.48 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.97 | 11589617 |
MESH:D002056 |
Burns |
|
Indomethacin |
4.32 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.61 | 11239499 16537180 15141370 15625704 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.14 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.07 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.01 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
11.01 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.16 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.16 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.60 | 14691202 16217749 15073043 15553829 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
15.60 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
15.60 | 16023760 16234567 18059187 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.60 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
15.60 | 17971768 17045692 16799960 18930000 17088986 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
15.60 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
15.60 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
15.60 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
4.33 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.96 | 14736730 11352223 18791128 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.76 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
5.76 | 18212800 18347146 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.57 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.47 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
9.75 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
9.75 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
9.75 | 17341418 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.78 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
16.42 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
16.42 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
16.42 | 16757204 17066447 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
16.42 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
16.42 | 15984520 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
16.42 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
6.05 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.05 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.27 | 16952015 17329180 15811867 17308081 15792986 17007740 16731534 15476868 16278810 17519947 15505089 17131338 17351982 16364871 16651473 16612575 16109756 16242529 17928571 17974986 18627295 17382496 16269455 17924179 16455267 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.80 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
marker/mechanism |
|
| 19696165 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.84 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
5.84 | 20056578 19524636 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Androstenedione |
6.45 | 21398041 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
6.45 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.83 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.77 | 11181007 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.93 | 15340226 8697196 16354765 15668235 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.43 | 17169374 18772588 17016597 16340194 17287894 17725105 17172411 16510598 17018589 15001691 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
5.43 | 15637740 15786552 15963497 15936596 15625704 11260862 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
5.43 | 19056647 11134977 16640504 17148506 17191121 19440933 15741050 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
7.80 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
7.80 | 18473752 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
7.80 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
7.80 | 17594712 20501625 18288408 18448328 18949393 16524972 16331619 17094418 17255274 17695437 15289873 18802399 17016601 16391804 14970324 18509181 17454858 16282729 17401013 15148649 18383874 16303861 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
7.80 | 18059344 11197048 17054584 12606626 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
7.80 | 18852136 18095365 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.81 | 12609071 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.43 | 17465463 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.32 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.33 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.33 | 10048152 20055451 15322242 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.18 | 12952375 16002989 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.40 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.73 | 15213294 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.42 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.57 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.08 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
3.43 | 7907874 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.46 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.46 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.14 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.14 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.75 | 18446180 16326151 18043480 12774134 17190690 16133044 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.77 | 11535926 10671773 17045617 17202747 17351913 11595431 11595415 16699067 11991626 17329845 17151854 |
MESH:D004487 |
Edema |
|
Indomethacin |
9.59 | 10653021 19703484 8273558 7907874 7990266 16100529 8985016 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
9.59 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.59 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.50 | 18230668 15322242 16714409 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.30 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
marker/mechanism |
|
| 16338060 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
11.02 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
11.02 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.02 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
7.94 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.94 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.75 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
4.11 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.35 | 17763956 10567023 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.60 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.67 | 11298111 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
9.47 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.47 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
9.47 | 16337965 16481741 15173087 17638652 16785472 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
9.47 | 11005569 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.72 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
2.95 | 15073043 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.41 | 16002989 16611131 15751030 16534752 16513791 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.07 | 11858732 |
MESH:D005334 |
Fever |
|
Indomethacin |
3.78 | 11852909 17627676 10431976 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.19 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.50 | 10962813 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
12.67 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
12.67 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.67 | 20067830 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.45 | 7506515 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.77 | 11298111 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
10.54 | 16904648 |
MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
10.54 | 19093184 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
4.35 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
11.50 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
11.50 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
biochanin A |
19.55 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
19.55 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
19.55 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
19.55 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
19.55 | 17162496 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
9.03 | 16145905 |
MESH:D005910 |
Glioma |
|
Indomethacin |
9.03 | 18371953 16487511 |
MESH:D005910 |
Glioma |
|
Quercetin |
9.03 | 17643826 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.97 | 11849393 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.19 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.96 | 11248219 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
16.35 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
16.35 | 15102660 15162350 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
16.35 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
16.35 | 15984520 18607998 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.73 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.73 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.21 | 16244371 16244372 18674790 16495754 16707910 17875725 16144979 18006777 14766674 16330681 17888722 16879835 12587719 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.10 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.55 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.98 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
4.22 | 15633222 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.31 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
7.39 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.39 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.63 | 15709030 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.25 | 17019078 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.34 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.39 | 18501091 15147373 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.39 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.35 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.64 | 16354765 18606429 16959395 15340226 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
7.23 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.23 | 12083418 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.32 | 17883296 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.91 | 17019078 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.61 | 12524144 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.69 | 18262572 11834736 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Superoxides |
4.94 | 12615666 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
3.80 | 17546600 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.05 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Quercetin |
4.69 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.69 | 18670907 18850075 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.31 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.80 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.19 | 16002989 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.62 | 10574470 18306037 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.96 | 10647630 16133968 10651667 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.45 | 7506515 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.97 | 16133044 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.98 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
Coumestrol |
6.60 | 16892005 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.60 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
7.21 | 3291741 7812673 12568917 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
7.21 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.21 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.11 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.71 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
9.22 | 15831440 10210152 11686837 18236018 11855677 11713966 17994277 17329856 15610444 |
MESH:D007410 |
Intestinal Diseases |
|
Superoxides |
9.22 | 10210152 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.97 | 15241188 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.62 | 16133968 10574470 18306037 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.57 | 17086741 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
16.61 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
16.61 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
16.61 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
16.61 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
16.61 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.80 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
10.67 | 15003126 14681315 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
10.67 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
10.67 | 16985049 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.68 | 17184923 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.59 | 12228301 10320625 11703811 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.80 | 15070760 |
MESH:D007938 |
Leukemia |
|
Quercetin |
5.80 | 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.75 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.44 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.91 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
7.59 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
7.59 | 10785260 15631656 16572323 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.41 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.81 | 20471514 17050201 16467208 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
3.81 | 18360721 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
2.96 | 12679006 16891316 12018890 11161223 15622746 15213294 17869043 11468182 16330433 16966277 16331271 16112521 9834237 17649720 15748426 16823087 17217047 19225113 15336539 17107899 19642359 19075265 17712046 19035177 12712474 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.98 | 16882451 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.97 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.32 | 17980183 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.83 | 8812269 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.32 | 11479899 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
10.03 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.03 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
10.03 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
naringenin |
10.03 | 14709902 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
10.03 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
silybin |
10.03 | 16169303 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.03 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
naringenin |
3.85 | 16945181 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
26.95 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
26.95 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
26.95 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
26.95 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
26.95 | 18383874 15113037 17045692 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
26.95 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
26.95 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
26.95 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
26.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
16.01 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
16.01 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
16.01 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
16.01 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.01 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.05 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.91 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
16.66 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
16.66 | 20135361 18816296 17053015 18569708 6695378 20869020 18520028 20064080 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
16.66 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
16.66 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
16.66 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
16.66 | 16537180 11497255 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
16.66 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
silybin |
16.66 | 16788158 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
16.66 | 19931552 17077188 16712894 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
16.66 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.40 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.75 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
6.81 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
6.81 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.47 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.18 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.76 | 11161223 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.11 | 16002989 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
8.61 | 19196723 19196722 15591091 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
8.61 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.61 | 11807958 17203775 16891317 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.08 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.22 | 16827129 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.22 | 16487513 19082730 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.90 | 17638057 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.40 | 11903285 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.15 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
12.68 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
12.68 | 18986760 16757204 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
12.68 | 12636206 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.40 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.83 | 11468182 19417148 19549372 14977855 15949261 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.27 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
2.91 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.44 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.44 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.71 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.56 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
7.56 | 19207477 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.59 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
8.84 | 12972520 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.84 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
8.84 | 16537180 11239499 11053908 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
20.92 | 11141357 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
20.92 | 16374040 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
20.92 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
20.92 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
naringenin |
20.92 | 15185748 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
20.92 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
20.92 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
8.00 | 15625704 10663608 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.00 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.38 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.34 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.38 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.67 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
14.21 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.21 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.21 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
6.47 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.47 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.05 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
3.62 | 12349958 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
4.00 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.17 | 16436463 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.57 | 9802331 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.77 | 6374098 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.43 | 7009135 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
3.86 | 19495926 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.80 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
10.17 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.17 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
10.17 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.17 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Indomethacin |
3.16 | 13679232 17627676 3291741 17440234 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.28 | 12538197 18702446 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
7.80 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
7.80 | 19003803 16500647 16929163 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
7.80 | 16965848 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.56 | 15028970 17883296 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.80 | 19927285 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.32 | 16537180 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.78 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.32 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.85 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.75 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.51 | 17225004 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.75 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.77 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.29 | 16977796 15687265 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.75 | 17638057 |
MESH:D011085 |
Polycystic Ovary Syndrome |
marker/mechanism |
|
| 16263811 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.18 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
3.65 | 19056647 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.74 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
14.06 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
14.06 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.06 | 11896295 11222880 11399792 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.69 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
9.69 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 18306354 17507624 |
MESH:D011471 |
Prostatic Neoplasms |
|
Apigenin |
4.01 | 17132221 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
4.01 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
4.01 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
biochanin A |
4.01 | 12111696 |
MESH:D011471 |
Prostatic Neoplasms |
|
Coumestrol |
4.01 | 16921512 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.01 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.01 | 15897917 16868541 16888761 16729912 15749863 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.01 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
4.01 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
4.01 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
4.01 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
3.80 | 11849393 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.68 | 18722050 15538739 16160472 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.84 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Superoxides |
4.32 | 18460982 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.46 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.65 | 18313854 16767912 15675481 17203757 15625365 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
9.03 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.03 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.40 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.14 | 16862918 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.80 | 16631401 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
11.95 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
11.95 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
11.95 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
11.95 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.18 | 15625365 16767912 17203757 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.31 | 16002989 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.49 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
4.03 | 16184426 10486359 15038085 10215738 16280098 10192188 17207306 17160473 18209964 15472012 17638125 16113693 18545984 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
5.92 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
5.92 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
5.92 | 17172411 17522103 19084572 18396642 15786421 16424979 19015929 17498489 16951190 18567086 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
5.92 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
5.92 | 18553229 16557585 18506536 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
3.25 | 16397915 10878458 11523592 18431645 15138204 17627676 16150113 17135157 12498302 18543354 12467913 10423059 11145282 10750652 15255614 1323529 15104355 16755016 12500499 16169175 18237397 11729361 12077510 18726076 14567935 16631530 16252198 12787963 18087811 18193104 11595431 17895592 11595415 18299717 17977527 17918041 18209962 11906479 18181030 17654042 16934674 17657623 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.50 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
10.38 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
10.38 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
10.38 | 14736730 18791128 11352223 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.28 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.65 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.57 | 15213294 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.50 | 10574470 17380554 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
17.73 | 12973940 20435036 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
17.73 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
17.73 | 16452187 17306315 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
17.73 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
17.73 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
17.73 | 16712894 17306315 11723127 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
13.94 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
13.94 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.94 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.77 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
3.70 | 15809267 16690809 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.05 | 16513791 16002989 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.03 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.19 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.84 | 17638931 16364871 17334414 17678736 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.35 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.85 | 15886252 |